Stress Disorder, Post Traumatic Clinical Trial
Official title:
Guided Imagery for Military Sexual Trauma-Related PTSD
Verified date | May 2010 |
Source | Duke University |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
Military sexual trauma (MST) is a significant women's mental health issue. There is a crucial need for effective therapies for MST-related posttraumatic stress disorder (PTSD) that are well-tolerated and can be flexibly administered in a variety of treatment settings. Guided imagery is a novel, transportable intervention technique that meets these requirements and warrants research in PTSD. The proposed study will be a randomized controlled trial of the Guided Imagery for Trauma (GIFT) intervention for women veterans with MST-related PTSD. This minimal contact intervention is designed to increase coping, affect management and relaxation skills, and to fostering more positive images and beliefs associated with surviving trauma. The feasibility and tolerability of GIFT have already been demonstrated in an open-label pilot of 15 women veterans with MST-related PTSD, with very promising initial results.
Status | Completed |
Enrollment | 40 |
Est. completion date | May 2010 |
Est. primary completion date | March 2010 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria: 1. Age 18-65 2. Status as a women veteran 3. Receives care at the Durham VAMC 4. History of MST, confirmed by CAPS interview 5. DSM-IV diagnosis of PTSD, confirmed by CAPS interview 6. Able to participate in a research interview in English. 7. Regular telephone access Exclusion Criteria: 1. Current diagnosis of organic, psychotic, or bipolar disorder 2. Suicidality or parasuicidality 3. Ongoing family violence 4. Alcohol or drug abuse within previous 3 months 5. Enrolled in cognitive-behavioral/exposure-based therapy for PTSD during study period. Supportive therapy and some psychiatric medications (if stabilized at least 3 months prior to enrollment) are acceptable. Although patients may use medications, no new medications will be started during the study. This includes, but is not restricted to, SSRIs, benzodiazepines, barbiturates, antiepileptic drugs, antidepressants, buspirone, non-benzodiazepine hypnotics, stimulants, or antipsychotics. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United States | Durham VA Medical Center | Durham | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Duke University | Durham VA Medical Center, National Institutes of Health (NIH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | PTSD Severity - Clinician Administered PTSD Scale (CAPS) | Midpoint and Endpoint | Yes | |
Secondary | Neuroactive Steroid assay | Endpoint | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00356278 -
D-cycloserine and Virtual Reality Exposure to Treat Iraq War Veterans With PTSD
|
Phase 2/Phase 3 | |
Completed |
NCT02560389 -
Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)
|
Phase 4 | |
Terminated |
NCT03990064 -
Benefits of Relaxation by Music Therapy on PTSD Symptoms
|
N/A |